Skip to main content
OpenTrials

Clinical trial condition

Hepadnaviridae Infections

Explore clinical trials studying Hepadnaviridae Infections. Study availability and eligibility vary by location and protocol.

1,149 public trials 113 recruiting studies
Refine in advanced search Browse all conditions

Hepadnaviridae Infections trial results

Completed

A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-H3733 in Subjects With Chronic Hepatitis B Virus Infection

NCT05414981

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • Diagnostic Consultative Center Aleksandrovska Sofia, Sofia-Grad, Bulgaria
  • Acibadem City Clinic Tokuda Hospital Sofia, Bulgaria
  • Military Medical Academy Multiprofile Hospital for Active Treatment - Sofia Sofia, Bulgaria
  • University of Hong Kong Hong Kong
View Trial Details
Completed

Chronic HBV Management for Asian American

NCT04082338

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Department of Psychology, Hunter College New York, United States
  • Center for Asian Health, Lewis Katz School of Medicine, Temple University Philadelphia, Pennsylvania, United States
View Trial Details
Completed

A Study of GSK3228836 in Participants With Chronic Hepatitis B (CHB)

NCT04449029

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Decatur, Georgia, United States
View all 121 locations
View Trial Details
Completed

HBV-HIV Coinfection Research Network

NCT01924455

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +21 more
Locations
  • University of California San Francisco, California, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • NIDDK Bethesda, Maryland, United States
  • Mass General Hospital Boston, Massachusetts, United States
View Trial Details
Completed

Combination Therapy of Pegylated Interferon Alfa-2a and Tenofovir Versus Tenofovir Monotherapy in Chronic Hepatitis B

NCT01369212

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • California Pacific Medical Center San Francisco, California, United States
  • University of California San Francisco San Francisco, California, United States
View all 21 locations
View Trial Details

Related conditions